Literature DB >> 8296270

Need for a comparative performance standard for dry powder inhalers.

R Richards1, M Saunders.   

Abstract

The efficacy of dry powder inhalers is dependent on the inspiratory flow rate at which they are used. The resistance to airflow through five different dry powder inhaler devices was measured. The devices were shown to vary significantly, with the Turbohaler having the highest resistance. We suggest that the performance of dry powder inhalers should be assessed at comparable pressure drops producing clinically relevant inspiratory flow rates for each device.

Mesh:

Substances:

Year:  1993        PMID: 8296270      PMCID: PMC464925          DOI: 10.1136/thx.48.11.1186

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).

Authors:  T Engel; J H Heinig; F Madsen; K Nikander
Journal:  Eur Respir J       Date:  1990-10       Impact factor: 16.671

2.  Influence of inspiratory flow rate upon the effect of a Turbuhaler.

Authors:  S Pedersen; O R Hansen; G Fuglsang
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

3.  Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique.

Authors:  R Richards; C R Dickson; A G Renwick; R A Lewis; S T Holgate
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

4.  How to use a rotahaler.

Authors:  S Pedersen
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

5.  Inhalation rate of sodium cromoglycate determines plasma pharmacokinetics and protection against AMP-induced bronchoconstriction in asthma.

Authors:  R Richards; S F Simpson; A G Renwick; S T Holgate
Journal:  Eur Respir J       Date:  1988-12       Impact factor: 16.671

  5 in total
  2 in total

Review 1.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

2.  Lymphoma, paraproteinaemia, and neuropathy.

Authors:  J H Wokke; J H Morris; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.